PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.76%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
2.97%
Positive gross profit growth while 8198.HK is negative. John Neff would see a clear operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
71.06%
Positive operating income growth while 8198.HK is negative. John Neff might view this as a competitive edge in operations.
136.02%
Positive net income growth while 8198.HK is negative. John Neff might see a big relative performance advantage.
135.09%
Positive EPS growth while 8198.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
135.09%
Positive diluted EPS growth while 8198.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
2.81%
Slight or no buybacks while 8198.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
2.75%
Slight or no buyback while 8198.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
2829.79%
Dividend growth of 2829.79% while 8198.HK is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-472.46%
Negative OCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-449.59%
Negative FCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
18.49%
10Y CAGR of 18.49% while 8198.HK is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
3.24%
Positive 5Y CAGR while 8198.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
23.17%
Positive 3Y CAGR while 8198.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-1171.24%
Negative 10Y OCF/share CAGR while 8198.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-39.56%
Negative 5Y OCF/share CAGR while 8198.HK is at 41.68%. Joel Greenblatt would question the firm’s operational model or cost structure.
-452.60%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-97.91%
Negative 10Y net income/share CAGR while 8198.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-96.95%
Negative 5Y net income/share CAGR while 8198.HK is 97.84%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-95.95%
Negative 3Y CAGR while 8198.HK is 60.24%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
22.47%
Below 50% of 8198.HK's 115.26%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
8.51%
Positive short-term equity growth while 8198.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-75.69%
Negative 5Y dividend/share CAGR while 8198.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-57.17%
Negative near-term dividend growth while 8198.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
0.99%
AR growth of 0.99% while 8198.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-19.74%
Inventory is declining while 8198.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-7.06%
Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.52%
We have a declining book value while 8198.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
17.00%
Debt growth of 17.00% while 8198.HK is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-100.00%
Our R&D shrinks while 8198.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-16.72%
We cut SG&A while 8198.HK invests at 147.82%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.